The Scientist - Home

This year’s most beautiful illustrations covered topics including the molecular underpinnings of Parkinson’s disease and strategies for tracking marine organisms around the world’s oceans.

Political newcomers to federal and state legislatures with STEM backgrounds are bringing evidence to drafting laws, yet getting bills passed remains elusive.

Health officials are rushing a genetically engineered product into the field to counter uncontained outbreaks of vaccine-derived polio.

Male researchers are more likely to describe their work in publications using positive superlatives than their female colleagues are, a habit tied to more citations.

The legislative package for 2020 allots $25 million for gun-violence research, which has been on hold for more than two decades.

Scientists track the spice from the soil to the market to pinpoint the source of contamination in pregnant women’s blood.

A journal is forced to remove a record-breaking number of papers—and all in one go.

A working group has put forth suggestions for cracking down on misconduct, such as requiring grant applicants to disclose sexual harassment findings.

The drug Vyondys 53 has met a surrogate endpoint of protein production, but there’s no clear proof it has a clinical benefit.

Wishing you a sciency season’s greetings!

A small RNA in Pseudomonas triggers an avoidance response in C. elegans that can be passed on to the next generation, according to research presented at this week’s meeting of the American Society for Cell Biology.

To advance the possibility of off-the-shelf cardiac cell therapies, scientists devise an engineered cardiac stem cell that avoids stimulating a detrimental immune attack.